Serina Therapeutics Inc (SER)

Serina Therapeutics Inc (SER) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $45.5M; returns 1 day -6.3%, 1 week -4.1%, 1 year -68.1%.

Serina Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing a pipeline of therapeutic product candidates utilizing its proprietary poly(2-oxazoline) (POZ) polymer drug delivery platform.

Groups SER belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Healthcare
• Life Sciences
• CNS Disorders
• Neurological Disorders
• Drug Discovery
• Neuroscience

SER financial model: income statement, cash flow and balance sheet